Phibro Animal Health | PAHC - Pre Tax Profit


Phibro Animal Health reported $38.62M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Align Technology USD 148.69M 193K Jun/2026
ANI Pharmaceuticals USD 40.22M 8.74M Mar/2026
Aurora Cannabis CAD 11.41M 12.99M Mar/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Canopy Growth CAD -157.96M 95.71M Mar/2026
Corcept Therapeutics USD -44.72M 54.62M Mar/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Henry Schein USD 137M 13M Jun/2026
Idexx Laboratories USD 417.22M 61.78M Jun/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Merck USD -3.53B 6.95B Mar/2026
Nektar Therapeutics USD -43.09M 8.39M Mar/2026
Pacira USD 5M 4.43M Mar/2026
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 64.77M 2.96M Mar/2026
Supernus Pharmaceuticals USD -57.65M 51.7M Jun/2026
Zoetis USD 758M 3M Mar/2026